Custom cover image
Remington essentials of pharmaceutics / edited by Linda A. Felton
Contributor(s): Resource type: Ressourcentyp: Buch (Online)Book (Online)Language: English Publisher: London and Chicago : Pharmaceutical Press, 2013Edition: Online-AusgDescription: Online-Ressource (1 online resource (x, 772 pages)) : illustrations (black and white)ISBN:- 9781306408806
- 1306408806
- 9780857111272
- 9780857111050
- Essentials of pharmaceutics
- Remington, the science and practice of pharmacy
- 615.1
- 615.19
- RS91
- RM301.25 .F384 2013
Contents:
Summary: Provides a concise yet detailed resource covering all aspects of pharmaceutics, from the scientific fundamentals to the dosage forms and drug delivery systems to drug product analyses. Assists with integrating the science of pharmacy into practicePPN: PPN: 807220094Package identifier: Produktsigel: ZDB-26-MYL | ZDB-30-PQE
9780857111050; Cover; Front Matter; Table of Contents; Preface; Contributors; Information Resources in Pharmacy and the Pharmaceutical Sciences; INTRODUCTION; LOCATING APPROPRIATE TYPES OF INFORMATION RESOURCES; Analysis of Medicinals; SPECIFICATIONS; COMPENDIA; MONOGRAPHS; RELEASE AND STABILITY TESTING; UNIVERSAL TESTS; METHOD VALIDATION FOR UNIVERSAL TESTS; TAXONOMY; DOSAGE FORMS-INJECTABLES; DOSAGE FORMS-ORAL DRUG PRODUCTS; ADDITIONAL DOSAGE FORMS; FUTURE DIRECTION; NAFCILLIN INJECTION; NAFCILLIN FOR INJECTION; CAPECITABINE TABLETS; PERFORMANCE TESTS; IMPURITIES; ADDITIONAL REQUIREMENTS
NAPROXEN DELAYED-RELEASE TABLETSACETAMINOPHEN EXTENDED-RELEASE TABLETS; Quality Assurance and Control; QA AND QC: ORGANIZATION/RESPONSIBILITIES; QUALITY BY DESIGN; DOCUMENTATION; QUALITY IN PHARMACEUTICAL BIOTECHNOLOGY; CONTEMPORARY ISSUES; FDA MODERNIZATION; PART 211 CURRENT GOOD MANUFACTURING PRACTICE FOR FINISHED PHARMACEUTICALS; Stability of Pharmaceutical Products; INTRODUCTION; REGULATORY REQUIREMENTS; PRODUCT STABILITY; PREDICTING SHELF LIFE; APPROXIMATIONS IN ASSESSING PRODUCT STABILITY; PHARMACEUTICAL CONTAINERS; CLOSURES; Bioavailability and Bioequivalence Testing; INTRODUCTION
DISSOLUTIONABSORPTION FACTORS; BIOEQUIVALENCE TESTING; METHODS FOR DETERMINING BIOEQUIVALENCE; MINIMIZING THE NEED FOR BIOEQUIVALENCE STUDIES; EVALUATION OF BIOEQUIVALENCE DATA; BIOEQUIVALENCE ASSESSMENT AND DATA EVALUATION; CRITERIA FOR BIOEQUIVALENCE; STUDY DESIGN; THERAPEUTIC EQUIVALENCE EVALUATIONS; Dissolution; DEFINITION OF DISSOLUTION AND THEORETICAL CONCEPTS FOR THE RELEASE OF THE DRUG FROM DOSAGE FORMS; MATHEMATICS OF DISSOLUTION; DISSOLUTION PROFILE COMPARISONS; APPLICATION OF QUALITY BY DESIGN (QbD) PRINCIPLES IN DISSOLUTION TESTING; Modern-Day Drug Discovery and Development
INTRODUCTIONEVOLUTION OF 21ST-CENTURY PHARMACEUTICAL RESEARCH; PHARMACEUTICAL RESEARCH ORGANIZATIONS; THE SEARCH FOR NEW DRUGS; NATURAL PRODUCT SOURCES; FUNCTIONS OF RESEARCH SCIENTISTS; DRUG DEVELOPMENT; The New Drug Approval Process; THE FOOD AND DRUG ADMINISTRATION; OVERVIEW OF THE US DRUG APPROVAL PROCESS; POST-APPROVAL ACTIVITIES; SUMMARY; Metrology and Pharmaceutical Calculations; WEIGHTS AND MEASURES; WEIGHING AND MEASURING; DENSITY AND SPECIFIC GRAVITY; PHARMACEUTICAL CALCULATIONS; LOGARITHMS; PHARMACEUTICAL PROBLEMS; REFERENCES; ANSWERS TO PROBLEMS; Statistics; INTRODUCTION
LOCATION PARAMETERSDESIGN OF EXPERIMENTS AND COLLECTION OF DATA; DESIGN AND CONDUCT OF CLINICAL TRIALS; DESIGN AND CONDUCT OF CLINICAL TRIALS; THE BINOMIAL AND NORMAL PROBABILITY DISTRIBUTIONS; THE BINOMIAL AND NORMAL PROBABILITY DISTRIBUTIONS; ESTIMATION AND STATISTICAL INFERENCE; DATA TRANSFORMATIONS; Molecular Structure, Properties, and States of Matter; MOLECULAR STRUCTURE AND PROPERTIES; STATES OF MATTER; Thermodynamics; INTRODUCTION; THE FIRST LAW; WORK AND HEAT; ENTROPY AND THE SECOND LAW; THE THIRD LAW; FREE ENERGY; STANDARD MOLAR GIBBS FREE ENERGY; NON-IDEALITY; EQUILIBRIA
SOLUBILITY
No physical items for this record